Brazilian Journal of Anesthesiology
https://bjan-sba.org/article/doi/10.1590/S0034-70942011000200013
Brazilian Journal of Anesthesiology
Review Article

Epilepsia e anestesia

Epilepsy and anesthesia

Marcius Vinícius Mulatinho Maranhão; Eni Araújo Gomes; Priscila Evaristo de Carvalho

Downloads: 2
Views: 1445

Resumo

JUSTIFICATIVA E OBJETIVOS: A epilepsia é uma doença neurológica crônica das mais frequentes. Embora a anestesia para portadores de epilepsia seja mais frequente em neurocirurgia, esse grupo de pacientes necessita, da mesma maneira que a população geral, de anestesia para dife rentes procedimentos diagnósticos e terapêuticos. Este artigo visou abordar os aspectos de maior interesse para o anestesiologista na conduta perioperatória do paciente epiléptico submetido à anestesia para procedimentos não neurocirúrgicos. CONTEÚDO: Abordam-se aspectos relevantes de fisiopatologia, classificação e diagnóstico da epilepsia; terapêutica anticonvulsivante e interações com drogas anestésicas; tratamento cirúrgico e dieta cetogênica; efeitos pró- e anticonvulsivante das drogas utilizadas em anestesia; avaliação pré-operatória, conduta intra- e pós-operatória no paciente epiléptico, bem como o diagnóstico e a terapêutica das convulsões perioperatórias. CONCLUSÕES: No manuseio perioperatório do paciente epiléptico é importante para o anestesiologista identificar o tipo de epilepsia; a frequência, a gravidade e os fatores desencadeantes das crises epileptogênicas; o uso de drogas anticonvulsivantes e as eventuais interações com as drogas utilizadas em anestesia; a presença de dieta cetogênica e de estimulador do nervo vago e suas implicações na técnica anestésica. É essencial o conhecimento das propriedades pró- e anticonvulsivantes dos fármacos utilizados na anestesia, minimizando o risco de atividade convulsiva no intra- e no pós-operatório. Por fim, é importante traçar o diagnóstico e realizar o tratamento das crises convulsivas perioperatórias, o que possibilita menor morbimortalidade.

Palavras-chave

DOENÇAS, Neurológicas

Abstract

BACKGROUND AND OBJECTIVES: Epilepsy is one of the most frequent chronic neurological diseases. Although anesthesia for epilepsy patients is more common in neurosurgery, this group of patients needs, just as the general population, anesthesia for different diagnostic and therapeutic procedures. This article aims to address the issues of greatest interest to the anesthesiologist in the perioperative management of epileptic patients undergoing anesthesia for non-neurosurgical procedures. CONTENT: We discuss relevant aspects of pathophysiology, classification and diagnosis of epilepsy; anticonvulsant therapy and interactions with anesthetic drugs; surgery and the ketogenic diet; pro-and anticonvulsant effects of drugs used in anesthesia; preoperative evaluation, intra- and postoperative conduct in epileptic patients, as well as the diagnosis and treatment of perioperative seizures. CONCLUSIONS: In the perioperative management of epileptic patients is important for anesthesiologists to identify the type of epilepsy, the frequency, severity and the factors triggering the epileptogenic crises; the use of anticonvulsant drugs and possible interactions with drugs used in anesthesia; the presence of ketogenic diet and stimulatory of the vagus nerve, and its implications in anesthetic techniques. It is essential the understanding of pro- and anticonvulsant properties of drugs used in anesthesia, minimizing the risk of seizure activity in the intra- and postoperative. Finally, it is important to outline the diagnosis and initiate treatment of seizures, perioperative, which offers lower both morbidity and mortality.

Keywords

Epilepsy, Anesthesia, Perioperative care, Seizures

Referencias

Yacubian EMT. Epilepsias. A Neurologia que Todo Médico Deve Saber. 2008:235-256.

Goldensohn ES. Historical Perspective. Epilepsy: Comprehensive Textbook. 1997:15-16.

Porter RJ. Classification of Epileptic Seizures and Epileptic Syndromes. Epilepsy: a Comprehensive Textbook. 1997:47-57.

Ren WHP. Anesthetic management of epileptic pediatric patients. Int Anesthesiol Clin. 2009;47:101-116.

Gallucci Neto J, Marchetti RL. Aspectos epidemiológicos e relevância dos transtornos mentais associados à epilepsia. Rev Bras Psiquiatr. 2005;27:323-328.

Censo Demográfico: Sinopse preliminar. 2003.

Hauser WA. Incidence and Prevalence. Epilepsy: a Comprehensive Textbook. 1997:47-57.

Pedroviejo V, Ayuso M, Jiménez A. Tratamiento anestésico del paciente adulto epiléptico no neuroquirúrgico. Rev Esp Anestesiol Reanim. 2009;56:425-435.

Aminof MJ. Nervous System Disorders. Current Medical Diagnosis and Treatment. 2009:878-889.

Arandas FS, Sena EP. Drogas Antiepilépticas. Farmacologia. 2006:416-423.

Kliemann FAD, Monte TL. Antiepilépticos. Farmacologia Clínica. 1998:332-347.

Dierdorf SF, Walton JS. Rare and Coexisting Diseases. Clinical Anesthesia. 2009:623-643.

Smith SJ. EEG in the diagnosis, classification, and management of patients with epilepsy. J Neurol Neurosurg Psychiatry. 2005;76(^s2):ii2-ii7.

Brown TR, Holmes GL. Epilepsy. N Engl J Med. 2001;344:1145-1151.

Stoelting RK. Antiepileptic Drugs. Pharmacology and Physiology in Anesthetic Practice. 2006:569-579.

Tripathi KD. Fármacos Antiepilépticos. Farmacologia Médica. 2006:323-332.

Ortenzi AV. Avaliação Pré- Anestésica. Tratado de Anestesiologia SAESP. 2006:1015-1039.

Hernandez AO, Lagunes JLV. Antiepilepticos: Farmacologiaclinica's Blog. 2008.

Groeper K, McCann MC. Topiramate and metabolic acidosis: a case series and review of the literature. Pediatr Anesth. 2005;15:167-170.

Valencia I. Monoterapia con los nuevos anticonvulsivantes. Acta Neurol Colomb. 2006;22:134-140.

Zaccara G, Specchio LM. Long-term safety and effectiveness of zonisamide in the treatment of epilepsy: a review of the literature. Neuropsychiatr Dis Treat. 2009;5:249-259.

Information for healthcare professional: zonisamide (FDA alert - february 23, 2009). .

Rizzutti S, Nishiyama AN, Muszkat M. Epilepsias: Tratamentos alternativos. Rev Neurociências. 1999;7:32-38.

Vasconcelos MM, Azevedo PMC, Esteves L. Dieta cetogênica para epilepsia intratável em crianças e adolescentes: relato de seis casos. Rev Assoc Med Bras. 2004;50:380-385.

Valencia I, Pfeifer H, Thiele EA. General anesthesia and the ketogenic diet: clinical experience in nine patients. Epilepsia. 2002;43:525-529.

Vuksanaj D, Deshpande JK. Anesthesia for neurosurgery in infants and children. ASA Refresher Courses Anesthesiol. 2008;36:215-226.

Van de Wiele B. Anesthesia for neurosurgery in infants and children. ASA Refresher Courses Anesthesiol. 2006;34:181-193.

Ramani R. Vagus nerve stimulation therapy for seizures. J Neurosurg Anesthesiol. 2008;20:29-35.

Pranzatelli MR, Tate ED. Chloral hydrate for progressive myoclonus epilepsy: a new look at an old drug. Pediatr Neurol. 2001;25:385-389.

Coté CJ, Karl HW, Notterman DA. Adverse sedation events in pediatrics: analysis of medications used for sedation. Pediatrics. 2000;106:633-644.

Olson DM, Sheehan MG, Thompson W. Sedation of children for electroencephalograms. Pediatrics. 2001;108:163-165.

Cortellazi P, Lamperti M, Minati L. Sedation of neurologically impaired children undergoing MRI: a sequential approach. Pediatr Anesth. 2007;17:630-636.

Modica PA, Tempelhoff R, White PF. Pro and anticonvulsante effects of anesthetics (Part 2). Anesth Analg. 1990;70:433-444.

Bhagat H, Dash HH. Anesthesiologist's role in the management of an epileptic patient. Indian J Anaesth. 2006;50:20-26.

Foutain NB, Adams RE. Midazolam treatment of acute and refractory status epilepticus. Clin Neurophamacol. 1999;22:261-267.

Morrison G, Gibbons E, Whitehouse WP. High-dose midazolam therapy for refractory status epilepticus in children. Intensive Care Med. 2006;32:2070-2076.

Brodie MJ. Drug interactions in epilepsy. Epilepsia. 1992;33(^s1):S13-22.

Watanabe S, Satumae T, Takeshima R. Opisthotonos after flumazenil administered to antagonize midazolam previously administered to treat developing local anesthetic toxicity. Anesth Analg. 1998;86:677-678.

Schulze-Bonhage A, Elger CE. Induction of parcial epileptic seizures by flumazenil. Epilepsia. 2000;41:186-192.

Taki H, Shinomura T, Shirakami G. A case of convulsion induced by flumazenil. Masui. 1996;45:1247-1251.

Ng KO, Tang GJ, Hseu SS. Seizures after reversal of benzodiazepine treatment with flumazenil: a report f two cases. Zhonghua Yi Xue Za Zhi. 1994;53:383-387.

Meyer S, Grundmann U, Kegel B. Propofol: pro or anticonvulsant drug. Anesth Analg. 2009;108:1993-1994..

Islander G, Vinge E. Severe neuroexcitatory symptoms after anaesthesia: with focus on propofol anaesthesia. Acta Anaesthesiol Scand. 2000;44:144-149.

Walder B, Tramer MR, Seeck M. Seizure-like phenomena and propofol: a systematic review. Neurology. 2002;58:1327-1332.

Sneyd JR. Propofol and epilepsy. Br J Anaesth. 1999;82:168-169.

Pitt-Miller PL, Elcock BJ, Maharaj M. The management of status epilepticus with a continuous propofol infusion. Anesth Analg. 1994;78:1193-1194.

Parviainen I, Kalviainen R, Ruokonen E. Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: pros and cons. Neurol Res. 2007;29:667-671.

De Riu PL, Petruzzi V, Testa C. Propofol anticonvulsant activity in experimental epileptic status. Br J Anaesth. 1992;69:178-181.

Kofke WA, Bloom MJ, Van Cott A. Electrographic tachyphylaxis to etomidate and ketamine used for refractory status epilepticus controlled with isoflurane. J Neurosurg Anesthesiol. 1997;9:269-272.

Avramov MN, Husain MM, White PF. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth Analg. 1995;81:596-602.

Ebrahim ZY, DeBoer GE, Luders H. Effect of etomidate on the electroencephalogram of patients with epilepsy. Anesth Analg. 1986;65:1004-1006.

Reddy RV, Moorthy SS, Dierdorf SF. Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital, and propofol. Anesth Analg. 1993;77:1008-1011.

Balakrishnan G, Grover KM, Mason K. A retrospective analysis of the effect of general anesthetics on the successful detection of interictal epileptiform activity in magnetoencephalography. Anesth Analg. 2007;104:1493-1497.

Sloan TB. Anesthetic effects on electrophysiologic recordings. J Clin Neurophysiol. 1998;15:217-226.

Szmuk P, Kee S, Pivalizza EG. Anaesthesia for magnetoencephalography in children with intractable seizures. Paediatr Anaesth. 2003;13:811-817.

Borris DJ, Bertram EH, Kapur J. Ketamine controls prolonged status epilepticus. Epilepsy Res. 2000;42:117-122.

Voss LJ, Sleigh JW, Barnard JP. The howling cortex: seizures and general anesthetic drugs. Anesth Analg. 2008;107:1689-1703.

Martin BS, Kapur J. A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation. Epilepsia. 2008;49:248-255.

Pruss H, Holtkamp M. Ketamine successfully terminates malignant status epilepticus. Epilepsy Res. 2008;82:219-222.

Burmeister-Rother R, Streatfeild KA, Yoo MC. Convulsions following ketamine and atropine. Anaesthesia. 1993;48.

Bruder N, Bonnet M. Agents pharmacologiques épileptogènes en anesthésie. Ann Fr Anesth Reanim. 2001;20:171-179.

Mason KP, O'Mahony E, Zurakowsk D. Effects of dexmedetomidine sedation on the EEG in children. Pediatr Anesth. 2009;19:1175-1183.

Oda Y, Toriyama S, Tanaka K. The effect of dexmedetomidine on electrocorticography in patients with temporal lobe epilepsy under sevoflurane anesthesia. Anesth Analg. 2007;105:1272-1277.

Souter MJ, Rozet I, Ojemann JG. Dexmedetomidine sedation during awake craniotomy for seizures resection: effects on electrocorticography. J Neurosurg Anesthesiol. 2007;19:38-44.

Ahmed SU, Vallejo R, Hord ED. Seizures after a Bier block with clonidine and lidocaine. Anesth Analg. 2004;99:593-594.

Schmitt H, Druschky K, Hummel C. Detection of an epileptic mirror focus after oral aplication of clonidine. Br J Anaesth. 1999;83:349-351.

Kirchberger K, Schmitt H, Hummel C. Clonidine and methohexital: induced epileptic magnetoencephalographic discharges in patients with focal epilepsies. Epilepsia. 1998;39:841-849.

Mehta UC, Patel I, Castello FV. EEG sedation for children with autism. J Dev Behav Pediatr. 2004;25:102-104.

Yokoyana M, Hirakawa M, Goto H. Clonidine does not affect lidocaine seizure threshold in rats. Can J Anaesth. 1993;40:1205-1209.

Modica PA, Tempelhoff R, White PF. Pro and anticonvulsant effects of anesthetics (Part 1). Anesth Analg. 1990;70:303-315.

Manninen PH, Burk SJ, Wennberg R. Intraoperative localization of an epileptogenic focus with alfentanil and fentanyl. Anesth Analg. 1999;88:1101- 1106.

Keene DL, Roberts D, Splinter WM. Alfentanil mediated activation of epileptiform activity in the electrocorticogram during resection of epileptogenic foci. Can J Neurol Sci. 1997;24:37-39.

McGuire G, El-Beheiry H, Manninen P. Activation of electrocorticographic activity with remifentanil and alfentanil during neurosurgical excision of epileptogenic focus. Br J Anaesth. 2003;91:651-655.

Tempelhoff R, Modica PA, Spitznagel EL Jr. Anticonvulsant therapy increases fentanyl requirements during anaesthesia for craniotomy. Can J Anaesth. 1990;37:327-332.

Kofke WA, Tempelhoff R, Dasheiff RM. Anesthesia for Epileptic Patients and for Epilepsy Surgery. Anesthesia and Neurosurgery. 1994:495-520.

Smith PA, McDonald TR, Jones CS. Convulsions associated with halothane anaesthesia: Two case reports. Anaesthesia. 1966;21:229-233.

Lebowitz MH, Blitt CD, Dillon JB. Enflurane induced central nervous system excitation and its relation to carbon dioxide tension. Anesth Analg. 1972;51:355-363.

Burchiel KJ, Stockard JJ, Myers RR. Metabolic and electrophysiologic mechanisms in the initiation and termination of enflurane: induced seizures in man and cats. Electroencephalogr Clin Neurophysiol. 1975;38.

Iijina T, Nakamura Z, Iwao Y. The epileptogenic properties of the volatile anesthetics sevoflurane and isoflurane in patients with epilepsy. Anesth Analg. 2000;91:989-995.

Mirsattari SM, Sharpe MD, Young GB. Treatment of refractory status epilepticus with inhalational anasthetic agents isoflurane and desflurane. Arch Neurol. 2004;61:1254-1259.

Constant I, Seeman R, Murat I. Sevoflurane and epileptiform EEG changes. Pediatr Anesth. 2005;15:266-274.

Vakkuri AP, Seitsonen ER, Jantti VH. A rapid increase in the inspired concentration of desflurane is not associated with epileptiform encephalogram. Anesth Analg. 2005;101:396-400.

Sharpe MD, Young GB, Mirsattari S. Prolonged desflurane administration for refractory status epilepticus. Anesthesiology. 2002;97:261-264.

Spacek A, Neiger FX, Krenn CG. Rocuronium-induced neuromuscular block is affected by chronic carbamazepine therapy. Anesthesiology. 1999;90:109-112.

Hernández-Palazón J, Tortosa JA, Martínez-Lage JF. Rocuronium-induced neuromuscular blockade is affected by chronic phenytoin therapy. J Neurosurg Anesthesiol. 2001;13:79-82.

Roth S, Ebrahim ZY. Resistence to pancuronium in patients receiving carbamazepine. Anesthesiology. 1987;66:691-693.

Wright PM, McCarthy G, Szenohradszky J. Influence of chronic phenytoin administration on the pharmacokinetics and pharmacodynamics of vecuronium. Anesthesiology. 2004;100:626-633.

Richard A, Girard F, Girard DC. Cisatracurium-induced neuromuscular blockade is affected by chronic phenytoin or carbamazepine treatment in neurosurgical patients. Anesth Analg. 2005;100:538-544.

Spacek A, Neiger FX, Spiss CK. Atracurium-induced neuromuscular block is not affected by chronic anticonvulsant therapy with carbamazepine. Acta Anaesthesiol Scand. 1997;41:1308-1311.

Ornstein E, Matteo RS, Schwartz AE. The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium. Anesthesiology. 1987;67:191-196.

Spacek A, Neiger FX, Spiss CK. Chronic carbamazepine therapy does not influence mivacurium-induced neuromuscular block. Br J Anaesth. 1996;77:500-502.

Spacek A, Nickl S, Neiger FX. Augmentation of the rocuronium-induced neuromuscular block by the acutely administered phenytoin. Anesthesiology. 1999;90:1551-1555.

Fodale V, Santamaria LB. Laudanosine, an atracurium and cisatracurium metabolite. Eur J Anaesthesiol. 2002;19:466-473.

Melton AT, Antognini JF, Gronert GA. Prolonged duration of succinylcholine in patients receiving anticonvulsivants: evidence for mild up-regulation of acetylcholine receptors?. Can J Anaesth. 1993;40:939-942.

Moore DC, Bridenbaugh LD, Brindenbaugh PO. Does compounding of local anesthetic agents increase their toxicity in humans?. Anesth Analg. 1972;51:579-585.

Abouleish EI, Elias M, Nelson C. Ropivacaíne-induced seizure after extradural anaesthesia. Br J Anaesth. 1998;80:843-844.

Moore DC, Brindenbaugh LD, Thompson GE. Bupivacaine: a review of 11080 cases. Anesth Analg. 1978;57:42-53.

Kopp SL, Wynd KP, Horlocker TT. Regional blockade in patients with a history of seizure disorder. Anesth Analg. 2009;109:272-278.

Sugimoto M, Uchida I, Mashimo T. Evidence of the involvement of GABA(A) receptor blockade in convulsions induced by cephalosporins. Neuropharmacology. 2003;45:304-314.

Cheng MA, Tempelhoff R. Anesthesia and epilepsy. Curr Opin Anaesthesiol. 1999;12:523-528.

Berish SM, Cascino GD, Warner ME. Effect of general anesthesia in patients with epilepsy: a population-based study. Epilepsy Behav. 2010;17:87-89.

Sethi D, Chhabra A. Seizure disorder leading to apnea and bradycardia in a 9-year-old child in immediate postoperative period. Pediatr Anesth. 2008;18:1211-1212.

Durham D. Management of status epilepticus. Crit Care Resusc. 1999;1:344-353.

5dd6d3a30e88254c7513f286 rba Articles
Links & Downloads

Braz J Anesthesiol

Share this page
Page Sections